A carregar...
The timeline of epigenetic drug discovery: from reality to dreams
The flexibility of the epigenome has generated an enticing argument to explore its reversion through pharmacological treatments as a strategy to ameliorate disease phenotypes. All three families of epigenetic proteins—readers, writers, and erasers—are druggable targets that can be addressed through...
Na minha lista:
| Publicado no: | Clin Epigenetics |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6888921/ https://ncbi.nlm.nih.gov/pubmed/31791394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-019-0776-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|